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Abstract
Objective:  To  compare  bacterial  growth  in  pure  colostrum  versus  colostrum  with  human  milk
fortiﬁer (HMF)  containing  iron.
Methods:  The  growth  of  Escherichia  coli,  Staphylococcus  aureus,  and  Pseudomonas  aeruginosa
in 78  samples  of  pure  colostrum  or  colostrum  with  added  iron-containing  HMF  was  compared.
For  qualitative  analysis,  ﬁlter  paper  discs  were  immersed  in  samples  from  each  group  and
incubated  for  48  hours  with  101 colony  forming  units  (CFUs)/mL  of  each  strain.  For  quantitative
assessment, 1  mL  of  each  strain  containing  107 CFUs/mL  was  homogenized  with  1  mL  of  either
colostrum  or  colostrum  with  human  milk  fortiﬁer,  seeded  into  a  Petri  dish,  and  incubated  at
37 ◦C.  Twenty-four  hours  later,  the  number  of  CFUs  was  counted.
Results: The  qualitative  analysis  showed  no  difference  in  bacterial  growth.  In  the  quantita-
tive evaluation,  E.  coli  growth  in  the  control  group  was  29.4  ±  9.7  ×  106 CFU/mL,  while  in  the
HMF  group  it  was  31.2  ±  10.8  ×  106 CFU/mL.  The  difference  between  the  average  growth  was
1.9  ±  4.9  ×  106 CFU/mL  (p  =  0.001).  There  were  no  differences  in  S.  aureus  and  P.  aeruginosa
growth.
Conclusion: Addition  of  iron  at  this  concentration  reduces  breast  milk  bacteriostatic  action
against E.  coli.
© 2013  Sociedade  Brasileira  de  Pediatria.  Published  by  Elsevier  Editora  Ltda.  
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Resumo
Objetivo:  Comparar  o  crescimento  bacteriano  em  colostro  puro  e  colostro  com  aditivo  do  leite
materno  contendo  ferro.
 Please cite this article as: Campos LF, Repka JCD, Falcao MC. Effects of human milk fortiﬁer with iron on the bacteriostatic properties
f breast milk. J Pediatr (Rio J). 2013;89:394--9.
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Métodos:  Foram  comparadas  78  amostras  de  colostro  puro  ou  colostro  com  adic¸ão  de  aditivo
do leite  materno  contendo  ferro  para  avaliar  o  crescimento  de  Escherichia  coli,  Staphylococ-
cus  aureus  e  Pseudomonas  aeruginosa.  Para  a  análise  qualitativa,  discos  de  papel-ﬁltro  foram
imersos  em  amostras  de  cada  grupo  e  incubados  por  48  horas  com  101 Unidades  Formadoras
de Colônias/mL  de  cada  cepa.  Para  a  avaliac¸ão  quantitativa,  1  mL  de  cada  cepa  contendo  107
Unidades  Formadoras  de  Colônias/mL  foi  homogeneizado  com  1  mL,  tanto  de  colostro  puro
quanto  de  colostro  com  aditivo  do  leite  materno,  espalhado  em  placa  de  Petri  e  incubado  a
37 ◦C.  O  número  de  Unidades  Formadoras  de  Colônias  foi  contado  24  horas  depois.
Resultados:  A  análise  qualitativa  não  mostrou  nenhuma  diferenc¸a no  crescimento  bacteri-
ano. Na  avaliac¸ão  quantitativa,  o  crescimento  de  Escherichia  coli  (EC)  no  grupo  C  foi  de
29,4  ±  9,7  ×  106 CFU/mL,  enquanto  no  grupo  FM85  foi  de  31,2  ±  10,8  ×  106 CFU/mL.  A  diferenc¸a
entre o  crescimento  médio  foi  de  1,9  ±  4,9  ×  106 CFU/mL  (p  =  0,001).  Não  houve  diferenc¸as  no
crescimento  de  Staphylococcus  aureus  e  Pseudomonas  aeruginosa.
Conclusão:  A  adic¸ão  de  ferro  a  essa  concentrac¸ão  reduz  a  ac¸ão  bacteriostática  do  leite  materno
contra Escherichia  coli.
© 2013  Sociedade  Brasileira  de  Pediatria.  Publicado  por  Elsevier  Editora  Ltda.  
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It  is  well  known  that  breast  milk  is  the  optimal  food  to
be offered  to  the  newborn  due  to  its  unique  growth  and
immunologic factors.1,2 It  has  been  shown  that  premature
newborns also  have  better  outcomes  when  fed  with  breast
milk.2--4 However,  due  to  the  high-energy  needs  of  prema-
ture newborns,  breast  milk  alone  is  often  insufﬁcient  to
meet their  nutritional  requirements,  especially  in  prema-
ture infants  who  weigh  less  than  1,500  g.4--6 In  such  small
infants, energy,  protein,  calcium,  phosphorus,  iron,  and
sodium intakes  should  be  increased,  and  the  advantages  of
breast milk  maintained  by  adding  human  milk  fortiﬁer  (HMF)
to breast  milk.4,6--10 The  only  HMF  available  at  the  moment  of
this study  in  Brazil  had  been  modiﬁed  to  contain  an  increased
amount of  iron  (0.28  mg  of  Fe  per  1  gram  of  product).
Among all  immunologic  beneﬁts  of  breast  milk,  the  bacte-
riostatic capacity  of  lactoferrin  is  remarkable.11 Lactoferrin
is an  iron-binding  protein  that  has  been  shown  to  have  activ-
ity against  bacteria,  viruses,  and  fungi;11,12 to  stimulate  the
immune system  and  the  mucosa  immune  function;11 and  to
have antioxidant  and  anti-carcinogenic  effects.11--13 Bovine
lactoferrin supplementation  has  been  shown  to  prevent  sep-
sis  in  very-low-birth-weight  neonates,  and  has  been  shown  to
reduce respiratory  tract  illness  and  increase  hematocrits  in
healthy bottle-fed  infants.14,15 In  human  breast  milk,  lacto-
ferrin acts  at  the  newborns’  mucosa  and  protects  them  from
infection by  binding  to  iron  and  depriving  it  from  patho-
logic bacteria  that  need  iron  to  proliferate.7--11 In  order  to
maintain this  bacteriostatic  capacity,  lactoferrin  needs  to  be
in an  environment  with  a  low  iron  concentration.  If  exoge-
nous iron  is  added  to  breast  milk,  the  beneﬁts  of  lactoferrin
might be  impaired,  which  in  turn  might  increase  the  risk  of
infection in  newborns.7--10
The  aim  of  this  study  was  to  compare  pathogenic  bac-
terial growth  in  colostrum  versus  colostrum  supplemented
with iron-enriched  HMF.
H
a
e
faterials and methods
olostrum  samples  were  collected  from  lactating  mothers
ho delivered  at  term  during  the  period  of  2010  and  2011.
0 mL  of  breast  milk  was  collected  from  each  mother.  The
nclusion criteria  were  lactating  white  healthy  mothers  who
elivered in  term.  The  exclusion  criteria  were  mothers  who
ad cesarean  deliveries,  receiving  antibiotic  treatment,  on
uspicion of  infection,  or  with  history  of  smoking.
The  mothers  were  approached  by  the  researcher  after
elivery, always  accompanied  by  obstetrics  and  gynecology
esident physicians.
The  participants  were  asked  about  their  pre-pregnancy
ody weight  and  age.  They  were  instructed  on  how  to  col-
ect the  breast  milk  in  an  aseptic  fashion.  Sample  collection
as performed  manually  or  with  a  manual  suction  pump,
ccording to  the  mother’s  preference.  Mothers  who  chose  to
se the  manual  suction  pump  received  an  ethylene  oxide-
terilized pump  containing  a  ﬂask,  a  polypropylene  tube,
nd a  latex  plunger,  and  were  verbally  oriented  on  how  to
se the  pump  (according  to  manufacturer’s  instructions).
The  samples  were  collected  in  sterilized  tubes  and  were
losed with  sterilized  rubber  stoppers.  Mothers  who  chose  to
se a  pump  collected  their  samples  in  a  coupled  tube,  closed
ith a  polypropylene  stopper.  In  the  laboratory,  each  sam-
le was  transferred  to  another  sterile  tube.  Each  of  these
ubes was  identiﬁed  with  a  label  containing  the  mother’s
ame and  the  sample  number,  as  well  as  the  day  and  hour  of
ollection.
The samples  were  kept  in  a  refrigerator  at  a  temperature
f 4 ◦C  to  6 ◦C,  and  analyzed  within  72  hours.  Each  sample
as divided  into  two  samples  of  5  mL,  one  to  be  analyzed
s control  (pure  human  milk),  and  the  other  with  added
MF. HMF  was  added  immediately  before  the  analyses,  in
 proportion  of  5%,  which  resulted  in  0.25  g  of  fortiﬁer  for
ach 5  mL  of  breast  milk  (manufacturer’s  instructions).  The
ortiﬁer was  weighed  with  an  analytical  balance.
3 Campos  LF  et  al.
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Figure  1  Bacterial  growth  of  Escherichia  coli  in  control  group
and human  milk  fortiﬁer  group  (HMF).
CEC,  bacterial  growth  of  E.  coli  in  control  group  (pure  breast
milk); FM85  EC,  bacterial  growth  of  E.  coli  in  HMF  group  (breast
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Proof  of  sterility  was  applied  to  all  samples  accord-
ng to  the  method  by  Almeida  and  Novak.16 The  samples
ere seeded  in  thioglycolate  broth  and  soy  tripcasein  broth.
.4 mL  of  breast  milk  were  added  to  10  mL  of  each  of  the
roths using  an  automated,  sterilized  pipette.  Samples  were
hen  incubated  at  36.4 ◦C  for  48  hours.  The  analyses  were
ade after  24  and  48  hours.
Qualitative evaluation  of  bactericidal  capacity  was
valuated according  to  the  methodology  proposed  by
he American  Society  for  Microbiology17 and  by  Chan.8
scherichia  coli,  Staphylococcus  aureus,  and  Pseudomonas
eruginosa were  obtained  from  clinical  isolate  strains  under
ultivation 18  to  24  hours  in  brain  hearth  infusion  (BHI)  agar.
Each  strain  of  bacteria  culture  was  prepared  at  37◦ C  BHI
roth in  agar  plate.  For  each  of  the  samples,  a  colony  was
esuspended in  saline  and  diluted  until  the  desired  concen-
ration (101 colony-forming  units  --  CFU/mL)  compared  to
he standard  pipe  scale  of  MacFarland.  Two  Petri  dishes  con-
aining BHI  agar  were  prepared  for  each  strain  of  bacteria,
nd individually  seeded  with  101 CFU/mL  of  each  strain,
dentiﬁed with  the  strain  and  the  sample  number.
Sterilized  discs  of  ﬁlter  paper  were  then  immersed  in
amples of  either  pure  breast  milk,  denoted  as  the  con-
rol (C)  group,  or  breast  milk  plus  HMF,  denoted  as  the  HMF
roup. The  discs  were  placed  in  the  Petri  dishes  and  incu-
ated for  48  hours.  The  inhibition  halos  were  then  measured.
our discs  were  placed  in  each  Petri  dish.  A  standard  model,
aintaining the  same  distances  between  discs,  determined
he locations  of  the  discs.
For  the  quantitative  assessment  of  breast  milk  samples,
he samples  were  evaluated  according  to  the  methodol-
gy proposed  by  Hernandez  et  al.18 The  same  samples  of
ure colostrum  and  fortiﬁed  colostrum,  as  well  as  the  same
trains of  bacteria  from  the  qualitative  assessment,  were
sed. However,  the  concentration  of  bacteria  was  now  at
07 CFU/mL.  1  mL  of  the  suspension  of  bacteria  with  either
 mL  of  pure  breast  milk  or  1  mL  of  breast  milk  plus  HMF
ere homogenized  in  a  magnetic  stirrer.  1  mL  of  this  mix-
ure was  seeded  into  Petri  dishes  with  BHI  agar.  The  dishes
ere then  incubated  at  37 ◦C  for  24  hours.  The  number  of
FUs was  counted  after  the  incubation  period.
The  sample  size  was  determined  by  SIGMA,  accepting
 margin  of  error  of  5%  and  variation  of  bacterial  growth
f 10%.  This  calculation  suggested  that  a  minimum  of  40
amples were  necessary.
tatistical  analysis
he  results  obtained  in  the  study  were  expressed  as  means
nd standard  deviations.  To  compare  the  bacterial  growth
etween colostrum  and  colostrum  with  HMF,  the  Student’s
-test for  paired  samples  was  used.  To  assess  the  correlation
etween the  two  types  of  milk,  Pearson’s  correlation  coefﬁ-
ient was  calculated.  This  same  statistical  analysis  was  used
o assess  the  correlation  between  the  number  of  bacteria
nd the  mother’s  age,  as  well  as  the  pre-pregnancy  weight.
 p-value  <0.05  was  considered  statistically  signiﬁcant.  Data
ere analyzed  with  the  computer  software  (StatSoft  Inc  --
SA).
The  research  protocol  was  approved  by  the  Research
thics Committee  of  the  Hospital  Angelina  Caron  and  by  the
t
n
ﬁilk +  FM85);  SE,  standard  error;  SD,  standard  deviation.
esearch  Ethics  Committee  of  the  Hospital  das  Clínicas  --
edical  School  of  the  Universidade  de  São  Paulo.  All  pro-
edures followed  the  ethical  standards  of  the  responsible
ommittee on  human  experimentation  of  both  institutions.
he procedures  were  also  in  accordance  with  the  Helsinki
eclaration of  1975.  All  participants  received  detailed
xplanation of  the  protocol  and  signed  an  informed  consent
etailing their  participation.
esults
eventy-eight  samples  of  breast  milk  were  collected.  Only
hree mothers  refused  to  donate  milk  sample,  two  because
f pain  and  one  for  personal  reasons.  The  average  age  of
he participants  was  25.2  ±  6.6  years  and  the  mean  pre-
regnancy body  weight  was  60.6  ±  10.1  kg.
The  proof  of  sterility  conﬁrmed  that  all  samples  were
terile. There  was  no  bacterial  growth  inhibition  in  any  sam-
le  by  the  qualitative  analysis,  as  there  was  no  evidence  of
nhibition halos  around  the  discs  of  the  C  group  or  the  HMF
roup.
The quantitative  evaluation  showed  that  the  mean  E.  coli
rowth in  the  C  group  was  29.4  ±  9.7  ×  106 CFU/mL,  while
n the  HMF  it  was  31.2  ±  10.8  ×  106 CFU/mL.  The  differ-
nce between  the  average  growth  in  C  and  HMF  group  was
.9 ±  4.9  ×  106 CFU/mL  (p  =  0.001)  (Fig.  1).
The mean  growth  of  S.  aureus  in  the  C  group
as 43  ±  11.6  ×  106 CFU/mL,  and  in  HMF  group  it  was
3.2 ±  12.6  ×  106 CFU/mL.  The  mean  difference  between
he two  groups  was  0.3  ±  4.5  ×  106 CFU/mL  (p  =  0.614).
he mean  growth  of  P.  aeruginosa  in  the  C  group  was
1.1 ±  12.0  ×  106 CFU/mL,  and  in  the  HMF  group  it  was
1.5 ±  12.0  ×  106 CFU/mL.  The  mean  difference  between
he two  groups  was  0.4  ±  3.0  ×  106 CFU/mL  (p  =  0.285).The  variables  pre-pregnancy  body  weight  and  age  were
ot correlated  with  bacterial  growth  (the  correlation  coef-
cient for  all  strains  was  p  >  0.05).
H
a
a
b
t
a
b
a
b
a
I
c
3
a
m
i
o
t
r
h
m
r
t
i
h
t
d
t
i
p
l
a
a
h
i
H
i
w
t
f
b
E
B
h
C
f
C
a
b
s
iHMF  and  bacterial  growth  in  breast  milk  
For  each  bacterial  strain,  the  correlation  coefﬁcient
between the  number  of  bacteria  in  both  the  C  group  and
the HMF  group  was  estimated.  The  correlation  coefﬁcient
between C  group’s  E.  coli  and  HMF  group’s  E.  coli  was  0.89
(p <  0.001);  between  C  group’s  S.  aureus  and  HMF  group’s  S.
aureus was  0.94  (p  <  0.001),  and  between  C  group’s  P.  aeru-
ginosa and  HMF  group’s  P.  aeruginosa  was  0.97  (p  <  0.001).
Discussion
All  samples  were  collected  within  two  days  of  delivery.  There
were no  bacterial  or  fungal  growth  in  the  samples  as  deter-
mined by  the  proof  of  sterility,  with  no  contamination  in
both collection  and  storage,  which  validates  the  applied
methodology.
The variables  age  and  pre-pregnancy  body  weight  showed
no correlation  with  bacterial  growth.  Prepregnancy  weight
was the  only  nutritional  parameter  evaluated  in  this  study.
Collado et  al.19 have  associated  the  immunomodulatory
function  of  human  milk  with  overweight  and  excessive
weight gain  during  pregnancy.  In  their  study,  overweight
mothers presented  lower  levels  of  TGF-  2  and  CD14  when
compared with  normal-weight  mothers.  Maternal  weight  and
weight gain  during  pregnancy  were  also  shown  to  affect
infants’ fecal  microbial  composition,  with  higher  levels  of
Staphyloccocus sp.  and  lower  levels  of  Biﬁdobacterium  sp.
in infants  of  normal-weight  mothers  with  normal  weight  gain
during pregnancy.19,20 Previous  studies  have  found  no  rela-
tionship between  maternal  hemoglobin  and  iron  levels  and
iron and  lactoferrin  content  in  their  breast  milk.21,22 Con-
versely, other  studies  have  shown  that  maternal  nutritional
status affects  human  milk  composition.23,24
The  variable  age  also  did  not  show  correlation  with
bacterial growth,  and  this  was  probably  because  an  adult
population (25.2  ±  6.6  years)  was  studied.  It  is  known  that
human milk  from  teenager  mothers  has  nutritional  deﬁcien-
cies due  to  their  fast  growth  during  this  period.25,26
It  was  decided  to  collect  colostrum,  similarly  to  other
studies, because  of  its  higher  concentration  of  lactoferrin,22
and  also  because  it  would  be  possible  to  standardize  lacto-
ferrin concentration  in  samples.  The  collection  was  also
easier because  samples  were  collected  immediately  after
birth, while  mothers  were  still  at  the  hospital.
The  qualitative  analysis  used  in  this  study  did  not  allow
for the  conﬁrmation  of  a  bacteriostatic  effect  of  milk;  since
there was  no  formation  of  a  bacterial  growth  inhibition  zone,
it was  not  possible  to  measure  the  halos,  in  contrast  to  the
results found  by  Chan  et  al.7,8 They  found  inhibition  of  bacte-
rial growth  by  pure  breast  milk  and  by  breast  milk  with  HMF
without the  addition  of  iron  (0.2  mg/100  mL  of  breast  milk),
but found  no  inhibition  in  bacterial  growth  when  the  breast
milk was  supplemented  with  HMF  that  contained  additional
iron (1.5  mg  of  iron  in  100  mL  of  breast  milk).
Santiago  et  al.10 compared  the  growth  of  Gram-positive
and Gram-negative  bacteria  in  breast  milk  samples  sup-
plemented with  the  same  HMF  used  by  Chan  et  al.7,8 The
authors performed  total  counts  of  bacteria  in  frozen  sam-
ples at  time  0,  24  hours,  and  72  hours  with  and  without
the addition  of  HMF.  They  found  no  difference  in  bacterial
growth reduction  in  both  groups,  and  also  concluded  that
the antibacterial  properties  of  human  milk,  with  or  without
i
t
o397
MF,  can  last  for  72  hours.  These  results  also  validate  the
pplied methodology  of  refrigeration.  Similarly,  Yuen  et  al.27
nalyzed  25  colostrum  and  11  mature  samples  of  milk  after
eing stored  at  4 ◦C  and  - 20 ◦C,  and  concluded  that  all  nutri-
ional and  immunological  factors  were  adequately  preserved
fter three  days  of  refrigeration.
Ovali  et  al.9 compared  the  bacteriostatic  capacity  of  pure
reast milk,  breast  milk  with  HMF  without  addition  of  iron,
nd breast  milk  with  ferrous  sulfate  (0.38  mg  in  30  mL  of
reast milk),  using  the  same  methodology  proposed  by  Chan,
nd with  the  same  bacterial  strains  used  in  the  present  study.
n contrast  to  the  results  of  the  present  study,  the  authors
oncluded that  the  addition  of  ferrous  sulfate  at  0.38  mg  in
0 mL  of  breast  milk  inhibited  the  bacteriostatic  capacity
gainst all  strains.
All  abovementioned  studies  analyzed  milk  samples  of
others who  delivered  prematurely,  while  the  present  study
ncluded mothers  who  delivered  in  term,  since  the  number
f premature  births  in  this  hospital  is  very  small.  It  is  impor-
ant to  note  that  this  might  be  a  reason  for  the  differing
esults.
Previous reports  on  lactoferrin  levels  in  preterm  milk
ave shown  either  signiﬁcantly  higher  values  than  term
ilk28 or  no  difference  between  them.29 Ronayne  de  Fer-
er et  al.30 found  no  difference  between  preterm  and
erm lactoferrin  values,  in  spite  of  the  trend  observed
n colostrum  samples,  where  term  milk  tended  to  show
igher levels  than  preterm  milk.  The  same  study,30 similarly
o others,22 showed  that  lactoferrin  concentration  values
ecrease, mainly  in  term  milk.  It  is  also  important  to  observe
hat studies  have  demonstrated  that  lactoferrin  levels  vary
n different  populations.31
In  the  present  study,  term  colostrum  was  used  instead  of
reterm colostrum,  and  this  might  be  a  limitation,  although
actoferrin levels  between  preterm  and  term  colostrum
ppear not  to  be  clearly  deﬁned.  When  the  present  results
re extrapolated  to  clinical  practice,  it  is  important  to
ighlight that,  although  HMF  is  currently  used  for  preterm
nfants, in  Brazil  a large  number  of  preterm  infants  receive
MF added  to  human  milk  from  the  Human  Milk  Bank,  and
n that  case  they  usually  receive  term  milk.
None  of  the  previous  studies  evaluated  bacterial  growth
ith the  addition  of  the  HMF  used  in  this  study,  which  is
he only  fortiﬁer  available  in  Brazil  (0.28  mg  of  iron  in  1  g  of
ortiﬁer). It  is  also  important  to  consider  that  in  the  studies
y Chan  et  al.,  different  bacteria  strains  were  analyzed:
. coli,  Staphylococcus,  Enterobacter  sakazakii,  and  group
 Streptococcus.  In  the  present  study,  E.  coli  growth  was
igher in  the  samples  with  HMF,  similarly  to  the  studies  by
han et  al.7,8
The  bacterial  strains  selected  for  this  study  are  the  most
requent reported  by  the  Commission  of  Hospital  Infection
ontrol of  the  hospital  where  the  study  was  performed.
The  correlation  coefﬁcients  between  C  group  samples
nd HMF  group  samples  were  signiﬁcant  for  all  strains  of
acteria, which  demonstrates  that  the  bacterial  growth  was
imilar in  all  samples  when  the  two  groups  were  compared,
ndicating that  bacterial  growth  followed  the  same  pattern
n both  groups,  regardless  of  the  addition  of  HMF.
The  mechanism  through  which  lactoferrin  inhibits  bac-
erial growth  remains  unclear.  The  bacteriostatic  capacity
f lactoferrin  is  often  attributed  to  its  ability  to  chelate
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298  
ron,  restricting  this  essential  nutrient  for  pathogenic  bacte-
ia proliferation.  However,  it  is  important  to  highlight  that
tudies have  also  shown  that  the  bactericidal  activity  is
ot dependent  on  the  degree  of  iron  saturation  of  lactofer-
in. Since  lactoferrin  has  been  shown  to  affect  the  immune
ystem and  the  mucosa  immune  function,  the  addition  of
ron may  affect  these  actions.  However,  since  the  present
tudy was  in  vitro,  it  was  not  possible  to  analyze  those
unctions.7,11--13,32,33
Care  should  be  taken  when  extrapolating  the  present
esults to  clinical  practice.  In  vitro,  it  appears  that  the  HMF
urrently available  in  Brazil  may  increase  the  risk  for  E.  coli
roliferation.  However,  in  vivo  studies  are  needed  to  test
he clinical  signiﬁcance  of  these  results.
Contradictory  results  found  in  similar  studies  are  proba-
ly due  to  different  milk  samples,  which  may  vary  depending
n ethnic  characteristics,  infant  age  at  the  delivery  time,
ilk maturity,  time  of  sample  collection,  added  iron
mount, and  strain  of  bacteria  analyzed.  Additional  studies
re needed  to  identify  the  degree  to  which  iron  can  interfere
ith the  bacteriostatic  capacity  for  each  bacterial  strain,
ince the  bacteriostatic  function  of  breast  milk  appears  to
epend upon  all  these  factors.
onclusion
his  study  demonstrated  that  iron  supplementation  with
.28 mg  of  iron  per  1  g  of  HMF  reduced  the  bacteriostatic
ction of  breast  milk  against  E.  coli  in  vitro;  however,  this
ffect was  not  observed  for  P.  aeruginosa  and  S.  aureus
trains. Further  in  vivo  studies  are  needed  to  determine  how
o extrapolate  these  data  to  clinical  practice.
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